Xilio Therapeutics Inc (XLO)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-01-03 | 2025-01-02 | PS Planned sale |
SVP, FINANCE AND ACCOUNTING Officer |
1,803
-36.1%
0.98USD 1,774 |
1,803 -36.1% | 0.98 | USD 1,774 | |
| 2025-01-03 | 2025-01-02 | PS Planned sale |
Frankenfield Christopher James Chief Financial Officer Officer |
6,954
-35.9%
0.98USD 6,841 |
6,954 -35.9% | 0.98 | USD 6,841 | |
| 2024-12-19 | 2024-12-18 | B Purchase | Large shareholder |
1,759,978
+24.0%
1.04USD 1,830,377 |
1,759,978 +24.0% | 1.04 | USD 1,830,377 | |
| 2024-04-03 | 2024-04-02 | B Purchase | Large shareholder |
485,250
+7.1%
0.76USD 368,790 |
485,250 +7.1% | 0.76 | USD 368,790 | |
| 2024-02-09 | 2024-02-08 | S Sale | Large shareholder |
267
-0.0%
0.64USD 171 |
267 -0.0% | 0.64 | USD 171 | |
| 2024-02-09 | 2024-02-08 | S Sale | Large shareholder |
733
-0.0%
0.64USD 469 |
733 -0.0% | 0.64 | USD 469 | |
| 2024-01-16 | 2024-01-12 | S Sale | Large shareholder |
560
-0.1%
0.83USD 465 |
560 -0.1% | 0.83 | USD 465 | |
| 2024-01-16 | 2024-01-12 | S Sale | Large shareholder |
1,540
-0.1%
0.83USD 1,278 |
1,540 -0.1% | 0.83 | USD 1,278 | |
| 2024-01-16 | 2024-01-11 | S Sale | Large shareholder |
569
-0.1%
0.87USD 495 |
569 -0.1% | 0.87 | USD 495 | |
| 2024-01-16 | 2024-01-11 | S Sale | Large shareholder |
1,566
-0.1%
0.87USD 1,362 |
1,566 -0.1% | 0.87 | USD 1,362 | |
| 2021-12-10 | 2021-12-10 | B Purchase |
Bain Capital Life Sciences Investors, LLC Large shareholder |
3,188
+0.1%
10.24USD 32,638 |
3,188 +0.1% | 10.24 | USD 32,638 | |
| 2021-12-10 | 2021-12-10 | B Purchase |
Bain Capital Life Sciences Investors, LLC Large shareholder |
21,812
+0.8%
9.56USD 208,564 |
21,812 +0.8% | 9.56 | USD 208,564 | |
| 2021-12-10 | 2021-12-09 | B Purchase |
Bain Capital Life Sciences Investors, LLC Large shareholder |
4,011
+0.1%
9.84USD 39,485 |
4,011 +0.1% | 9.84 | USD 39,485 | |
| 2021-12-10 | 2021-12-08 | B Purchase |
Bain Capital Life Sciences Investors, LLC Large shareholder |
13,458
+0.5%
9.62USD 129,474 |
13,458 +0.5% | 9.62 | USD 129,474 | |
| 2021-10-28 | 2021-10-26 | B Purchase | Large shareholder |
387,500
+51.2%
16.00USD 6,200,000 |
387,500 +51.2% | 16.00 | USD 6,200,000 | |
| 2021-10-28 | 2021-10-26 | B Purchase | Large shareholder |
387,500
+51.2%
16.00USD 6,200,000 |
387,500 +51.2% | 16.00 | USD 6,200,000 | |
| 2021-10-26 | 2021-10-26 | B Purchase | Large shareholder |
187,500
+34.2%
16.00USD 3,000,000 |
187,500 +34.2% | 16.00 | USD 3,000,000 | |
| 2021-10-26 | 2021-10-26 | B Purchase |
Rock Springs Capital Management LP Large shareholder |
500,000
+66.1%
16.00USD 8,000,000 |
500,000 +66.1% | 16.00 | USD 8,000,000 | |
| 2021-10-26 | 2021-10-26 | B Purchase | Large shareholder |
312,500
+38.3%
16.00USD 5,000,000 |
312,500 +38.3% | 16.00 | USD 5,000,000 | |
| 2021-10-26 | 2021-10-26 | B Purchase |
RiverVest Venture Fund IV, L.P. Large shareholder |
250,000
+21.0%
16.00USD 4,000,000 |
250,000 +21.0% | 16.00 | USD 4,000,000 |